Please join us at this exciting conference, share the latest information of regulatory trends in translational medicine, network with industry and regulatory professionals, and explore various job openings available on site!
–FDA’s focus on data integrity and supply chain oversight in the global pharmaceutical industry
–Understanding FDA’s inspectional, compliance, and enforcement operations regarding pharmaceuticals and biotechnology, and who the key players are
–Public Health Emergency Countermeasures: Regulatory pathways and considerations for selling products in the U.S. that combat bioterrorism, pandemics, and other biological hazards
–Marketing of Dietary Supplements and Medical Foods in the U.S. : A Regulatory Primer
–Cell, Tissue, and Gene Therapies: Regulatory pathways and considerations for selling regenerative medicine products in the U.S.
–Precision Medicine: Targeted therapeutics and companion diagnostics
–Drug Supply Chain Security under the Drug Supply Chain Security Act
–FDA medical device inspections – what FDA looks for and recent trends in FDA enforcement